StonvexLoading…
StonvexStonvexStonvexCore line items from OPHC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $19.45M | $64.35M | $46.92M | $30.59M |
Operating Income | $6.20M | $22.17M | $15.71M | $10.05M |
Net Income | $4.66M | $16.65M | $11.79M | $7.47M |
EPS (Diluted) | $0.20 | $0.71 | $0.50 | $0.61 |
Total Assets | $1.27B | $1.11B | $1.08B | $999.13M |
Total Liabilities | $1.14B | $989.78M | $966.15M | $887.78M |
Cash & Equivalents | Not available | Not available | Not available | Not available |
Free Cash Flow OCF − CapEx | $7.43M | $16.95M | $10.62M | $8.71M |
Shares Outstanding | 12.17M | 11.53M | 11.88M | 11.75M |